Add Company
Join Now

Surgenex Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Surgenex's estimated annual revenue is currently $13M per year.(i)
  • Surgenex's estimated revenue per employee is $155,000

Employee Data

  • Surgenex has 84 Employees.(i)
  • Surgenex grew their employee count by 83% last year.

Surgenex's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Chief Quality and Regulatory OfficerReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Commercial OfficerReveal Email/Phone
5
VP, Government Affairs and Health PolicyReveal Email/Phone
6
Director Regulatory AffairsReveal Email/Phone
7
Global director regulatory affairs, quality assurance and complianceReveal Email/Phone
8
Director Business DevelopmentReveal Email/Phone
9
National Accounts ManagerReveal Email/Phone
10
Processing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$0.9M60%N/AN/A
#3
$0.8M5-29%N/AN/A
#4
$5.3M340%N/AN/A
#5
$2.5M16-20%N/AN/A
#6
$1.1M70%N/AN/A
#7
$0.9M60%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$171.9M1109-3%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is Surgenex?

SURGENEX® is the producer and distributor of the highest quality amniotic membrane tissue allografts in the industry. Human Amniotic Tissue (hAM) is used in a wide variety of clinical settings including: Orthopaedics Sports Medicine Podiatry Pain Management Joint Care SURGENEX® has developed innovative processes and safety protocols, which deliver the highest quality and safety standards. With these safety and quality standards, SURGENEX® is the leader of amniotic membrane tissue allografts in the field of regenerative medicine. The SURGENEX® proprietary Excellion® process is used to produce SurForce®. This patented process is a highly manual and surgical harvesting procedure which generates the highest yield of amniotic tissues. Our placenta recovery processes start where life begins. Qualified mothers donate their placenta for medical treatments and research. These donors are selected through a strict screening process which includes an extensive patient questionnaire, serological testing, and a medical staff interview to ensure donor eligibility. The Excellion® process honors these donations by meticulously collecting the amniotic membrane and carefully removing unwanted tissues such as the chorion. This highly technical process produces the highest quality and the best amniotic tissue allograft in the industry. Learn more at surgenex.com and surgenexcatalog.com!

keywords:N/A

N/A

Total Funding

84

Number of Employees

$13M

Revenue (est)

83%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.6M8429%N/A
#2
$18.5M849%N/A
#3
$21.5M8539%N/A
#4
$11.9M85-6%N/A
#5
$12.3M8570%N/A